Sheffied Tabletting System Disintequik MCC 25 is a co-processed excipient consisting of 75% Alpha monohydrate lactose and 25% Microcrystalline Cellulose (MCC). The processing results in a co-agglomeration compound of the two ingredients, spray dried lactose and MCC, preserving the identity of each component. Prior to processing, both ingredients meet all of the requirements as outlined in the current monographs of the EU, JP and NF. Disintequick MCC 25 reduces raw materials QC Testing, Manufacturing Steps and process validation. A Drug Master File is available. Added benefits include: reduction of blending issues, low dust generation, the avoidance of costly wet granulation processes, improved flowability and content uniformity during compression.

BICAR®PHARMA API is suitable to be used as active pharmaceutical ingredient (API) in Antacid formulations like tablets, Capsules and Liquid oral formulation. It is also used as a Buffering agent and in effervescent formulations. Also used in effervescent tablets of lipid lowering agent.